|
|
||||||||



*
Transplantation Biology Research Center and
Division of Cardiac Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA 02114;
Repligen Corporation, Needham, MA 02494; and
Laboratory of Immunogenetics and Transplantation, Renal Division, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, MA 02115
The mechanisms by which CTLA4Ig exerts its powerful immunomodulatory effects are not clear. We show here that CTLA4Ig can induce linked regulation of allogeneic porcine T cell responses in vitro. Naive miniature swine SLAdd T cells were rendered hyporesponsive to specific allogeneic Ag after coculturing with MHC-mismatched SLAcc stimulators in the presence of CTLA4Ig. These Ag-specific hyporesponsive T cells were subsequently able to actively inhibit the allogeneic responses of naive syngeneic T cells in an MHC-linked fashion, as the responses of naive SLAdd responders against specific SLAcc and (SLAac)F1 stimulators were inhibited, but allogeneic responses against a 1:1 mixture of SLAaa (Ia, IIa) and SLAcc (Ic, IIc) were maintained. This inhibition could be generated against either class I or class II Ags, was radiosensitive, and required cell-cell contact. Furthermore, the mechanism of inhibition was not dependent upon a deletional, apoptotic pathway, but it was reversed by anti-IL-10 mAb. These data suggest that CTLA4Ig-induced inhibition of naive allogeneic T cell responses can be mediated through the generation of regulatory T cells via an IL-10-dependent mechanism.
This article has been cited by other articles:
![]() |
B. W. Soper, M. D. Lessard, C. D. Jude, A. J. T. Schuldt, R. M. Bunte, and J. E. Barker Successful Allogeneic Neonatal Bone Marrow Transplantation Devoid of Myeloablation Requires Costimulatory Blockade J. Immunol., September 15, 2003; 171(6): 3270 - 3277. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Elhalel, J.-H. Huang, W. Schmidt, J. Rachmilewitz, and M. L. Tykocinski CTLA-4 {middle dot} FasL Induces Alloantigen-Specific Hyporesponsiveness J. Immunol., June 15, 2003; 170(12): 5842 - 5850. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Guillot, S. Menoret, C. Guillonneau, C. Braudeau, M. G. Castro, P. Lowenstein, and I. Anegon Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig Blood, April 15, 2003; 101(8): 3325 - 3333. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Lee, K. Yamada, S. L. Houser, K. L. Womer, M. E. Maloney, H. S. Rose, M. H. Sayegh, and J. C. Madsen Indirect recognition of allopeptides promotes the development of cardiac allograft vasculopathy PNAS, March 13, 2001; 98(6): 3276 - 3281. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |